Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients

被引：0
|
作者：
机构：
[1] Barton Pai, A.
[2] Lin, S.
[3] Arruda, J.A.L.
[4] Lau, Alan H.
来源：
Lau, A.H. (alanlau@uic.edu) | 1600年 / Wichtig Editore s.r.l.卷 / 26期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients
    Pai, AB
    Lin, S
    Arruda, JAL
    Lau, AH
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2003, 26 (06): : 484 - 490
  • [2] Paricalcitol in Hemodialysis Patients with Secondary Hyperparathyroidism: A Long-Term Case Report
    Chen, Haoxiong
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 788 - 788
  • [3] The Impact of Paricalcitol on Parathyroid Gland Size of Secondary Hyperparathyroidism Patients with Long-Term Maintenance Hemodialysis: An Observational Study
    Tao, Chenghui
    Liao, Xiaohui
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 210 - 210
  • [4] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Shigematsu, Takashi
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Akiba, Takashi
    Fujii, Akifumi
    Odani, Motoi
    Akizawa, Tadao
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 426 - 436
  • [5] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Takashi Shigematsu
    Masafumi Fukagawa
    Keitaro Yokoyama
    Takashi Akiba
    Akifumi Fujii
    Motoi Odani
    Tadao Akizawa
    [J]. Clinical and Experimental Nephrology, 2018, 22 : 426 - 436
  • [6] ORAL MANIFESTATIONS OF SECONDARY HYPERPARATHYROIDISM RELATED TO LONG-TERM HEMODIALYSIS THERAPY
    FLETCHER, PD
    SCOPP, IW
    HERSH, RA
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1977, 43 (02): : 218 - 226
  • [7] Long-term effect of paricalcitol in hemodialysis patients.
    Pai, AB
    Lin, S
    Arruda, J
    Lau, AH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P92 - P92
  • [8] EFFECTIVENESS AND SAFETY OF ORAL PARICALCITOL ON LONG-TERM TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN KIDNEY TRANSPLANT PATIENTS
    Massimetti, Carlo
    Imperato, Gea
    De Galasso, Lara
    Feriozzi, Sandro
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [9] CONTROL OF SECONDARY HYPERPARATHYROIDISM DURING LONG-TERM HEMODIALYSIS
    JOHNSON, WJ
    GOLDSMIT.RS
    ARNAUD, CD
    JOWSEY, J
    KELLY, PJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1971, 74 (05) : 831 - +
  • [10] CONTROL OF SECONDARY HYPERPARATHYROIDISM DURING LONG-TERM HEMODIALYSIS
    FURSZYFER, J
    GOLDSMITH, RS
    JOHNSON, WJ
    ARNAUD, CD
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1970, 76 (06): : 1036 - +
12345